Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire

Recruiting N/A Interventional Study
Endometrial Cancer Lynch Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 and older
Sex
Female
Study type
Interventional
Purpose
Screening
Participants needed
30 (estimated)
Sponsor
University of British Columbia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this study is to find out if self-collected vaginal swabs can be used to detect early signs of uterine cancer or related conditions in people with Lynch syndrome (LS) who still have their uterus. The study also tests if people with LS are willing and able to collect these samples themselves and whether they find the process acceptable. The main questions this study asks are: * Will p…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosed with Lynch syndrome (confirmed by genetic testing). * Have an intact uterus. * Age 30 years or older. Exclusion Criteria: * History of endometrial cancer or endometrial hyperplasia. * History of pelvic radiation or endometrial ablation. * Pregnant at the time of st…
Contacts

Aline Talhouk, PhD

604-875-4111

a.talhouk@ubc.ca

CONTACT

Research Assistant

604-875-4111

CONTACT